Canada Wearable Injectors Market Insight
Published: 20 May 2026 | Report Format: Electronic (PDF)
The Canada wearable injectors market size is growing at a 15.02%CAGR, market arises due to the rising chronic diseases and biologics adoption drive wearable injectors and home healthcare demand in Canada.
Canada Wearable Injectors Market Insights Forecasts to 2035
- The Canada Wearable Injectors Market Size Was Estimated at USD501.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 15.02%from 2025 to 2035
- The Canada Wearable Injectors Market Size is Expected to Reach USD 2031.4 Million by 2035
Notable Insights for Canada Wearable Injectors Market
- According to the product type, On-body injectors constituted almost 58-60% market share in 2025 because of their increased use in delivering drugs biologically and in conditions that demand slow and controlled drug release.
- In terms of application, oncology occupied around 33-35% market share due to an increase in cases of cancer and higher adoption of wearables in administering biologics for cancer therapy.
- There is continuous growth in Health Canada's regulations regarding advanced drug delivery and connected healthcare technology products as the government invests more than CAD 18 billion towards healthcare innovation in Canada.
Download the eBook (ToC)
- Data released by the Canadian government shows an increase in the number of aged people and hence over 32% demand for home health management and wearables among Canadians.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada wearable injectors market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Canada Wearable Injectors Market
- Amgen Inc.
- Medtronic plc
- Becton, Dickinson and Company (BD)
- West Pharmaceutical Services
- Ypsomed Holding AG
- Enable Injections
- Insulet Corporation
- Gerresheimer AG
- United Therapeutics Corporation
- Tandem Diabetes Care
Recent Developments:
- In January 2026, Health Canada strengthened medical device regulations for digital health and wearable technologies, ensuring safety and effectiveness, supporting AI-driven connected devices, with over CAD 12 billion healthcare innovation investments across Canada’s expanding wearable medical technology market
- In July 2025, BD invested over USD 85 million in the United States to expand BD Libertaswearable injector technologies, supporting biologics delivery, connected patient monitoring, and home-based self-injection solutions across Canada and North America’s growing healthcare market.
- In June 2024, West Pharmaceutical Services invested over USD 70 million in the United States to expand SmartDose wearable injector systems, enabling 10mL biologics delivery, improving self-administration, and strengthening chronic disease home healthcare solutions across Canada.
Market Segmentation:
Canada Wearable Injectors Market, By Product Type
- On-Body Injectors
- Off-Body Injectors
Canada Wearable Injectors Market, By Technology
- Spring-Based
- Motor-Driven
- Rotary Pump
- Expanding Battery
- Others
Canada Wearable Injectors Market, By Application
- Oncology
- Diabetes
- Cardiovascular Diseases
- Autoimmune Disorders
- Infectious Diseases
- Others
Canada Wearable Injectors Market, By End User
- Hospitals
- Homecare Settings
- Specialty Clinics
- Ambulatory Care Centers
- Others
Expert Views:
The Canada’s wearable injectors market is projected to grow rapidly in the coming years owing to the rising acceptance of biologics drugs, high demand for self-administration devices, and increased focus on home care programs. Adoption of wearable injectors in combination with connected health technology, artificial intelligence-driven compliance monitoring, and telemedicine will bring about drastic changes in chronic disease management in Canada in the coming decade.
Author: Govind and Krishna By Spherical Insights and Consulting